Protecting CRISPR/Cas Genome Editing in Plant SystemsMarch 8, 2024

Penn State professor of plant pathology Yinong Yang’s multiplex RNA genome editing technology may produce gene therapy to correct defects that cause human diseases such as sickle-cell anemia and cystic fibrosis. He pioneers the successful use of CRISPR/Cas genome editing in plant systems, for which he filed an invention disclosure and a patent application in 2013. MVS attorneys prosecuted Professor Yang’s patents 10,308,947 and 11,702,667.